Chemotherapy in metastatic breast cancer: A summary of all randomised trials reported 2000-2007.
@article{Wilcken2008ChemotherapyIM, title={Chemotherapy in metastatic breast cancer: A summary of all randomised trials reported 2000-2007.}, author={N. Wilcken and Rachel F Dear}, journal={European journal of cancer}, year={2008}, volume={44 15}, pages={ 2218-25 } }
AIM
To summarise the findings of all randomised trials comparing chemotherapy regimens for metastatic breast cancer that were reported between 2000 and 2007 inclusive.
METHODS
We searched the specialised register of clinical trials maintained by the secretariat of the Cochrane Breast Cancer Group (CBCG) from 2000 to 2007, and abstracts from the American Society of Clinical Oncology (ASCO) annual scientific meeting (2000-2007).
RESULTS
Eighty reports of 63 trials were identified as eligible… CONTINUE READING
Topics from this paper
57 Citations
In the end what matters most? A review of clinical endpoints in advanced breast cancer.
- Medicine
- The oncologist
- 2011
- 59
Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome
- Medicine
- Breast Cancer Research and Treatment
- 2015
- 13
An overview of randomized clinical trials in metastatic breast cancer: variables affecting regulatory drug approval
- Medicine
- Anti-cancer drugs
- 2014
- 4
Overall survival and post-progression survival in advanced breast cancer: a review of recent randomized clinical trials.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2010
- 132
Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994–1998 and 2003–2006
- Medicine
- Breast Cancer Research and Treatment
- 2010
- 11
- PDF
Twenty-twenty hindsight: an adjuvant breast cancer trial through the retrospectoscope.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2014
- 2
Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life.
- Medicine
- Deutsches Arzteblatt international
- 2010
- 94
- PDF
Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience.
- Medicine
- Annals of oncology : official journal of the European Society for Medical Oncology
- 2011
- 78
Survival of de novo stage IV breast cancer patients over three decades
- Medicine
- Journal of Cancer Research and Clinical Oncology
- 2016
- 19
References
SHOWING 1-10 OF 61 REFERENCES
Single agent versus combination chemotherapy for metastatic breast cancer.
- Medicine
- The Cochrane database of systematic reviews
- 2009
- 190
Platinum containing regimens for metastatic breast cancer.
- Medicine
- The Cochrane database of systematic reviews
- 2004
- 55
Addition of drug/s to a chemotherapy regimen for metastatic breast cancer.
- Medicine
- The Cochrane database of systematic reviews
- 2010
- 23
Antitumour antibiotic containing regimens for metastatic breast cancer.
- Medicine
- The Cochrane database of systematic reviews
- 2004
- 25
Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients. clinical outcomes and oncologists' preferences.
- Medicine
- European journal of cancer
- 2003
- 48
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2004
- 194
Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.
- Medicine
- The Lancet. Oncology
- 2007
- 173
Gemcitabine plus docetaxel: a new treatment option for anthracycline pretreated metastatic breast cancer patients?
- Medicine
- Cancer treatment reviews
- 2005
- 16
Phase III trial comparing three doses of docetaxel for second-line treatment of advanced breast cancer.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2006
- 141